Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Total Current Liabilities: 2011-2025

Historic Total Current Liabilities for Mimedx Group (MDXG) over the last 14 years, with Sep 2025 value amounting to $57.7 million.

  • Mimedx Group's Total Current Liabilities rose 37.53% to $57.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.7 million, marking a year-over-year increase of 37.53%. This contributed to the annual value of $45.6 million for FY2024, which is 0.90% down from last year.
  • Latest data reveals that Mimedx Group reported Total Current Liabilities of $57.7 million as of Q3 2025, which was up 14.70% from $50.3 million recorded in Q2 2025.
  • Mimedx Group's Total Current Liabilities' 5-year high stood at $57.7 million during Q3 2025, with a 5-year trough of $36.6 million in Q1 2022.
  • Its 3-year average for Total Current Liabilities is $45.0 million, with a median of $43.6 million in 2023.
  • As far as peak fluctuations go, Mimedx Group's Total Current Liabilities tumbled by 33.96% in 2022, and later skyrocketed by 37.53% in 2025.
  • Quarterly analysis of 5 years shows Mimedx Group's Total Current Liabilities stood at $42.4 million in 2021, then climbed by 2.83% to $43.6 million in 2022, then increased by 5.63% to $46.0 million in 2023, then declined by 0.90% to $45.6 million in 2024, then surged by 37.53% to $57.7 million in 2025.
  • Its last three reported values are $57.7 million in Q3 2025, $50.3 million for Q2 2025, and $42.6 million during Q1 2025.